• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

The Global Pharmaceutical Manufacturing Market Will Grow to $509.45 Billion By 2026, at a CAGR of 12.38% – ResearchAndMarkets.com

Share:

May 31, 2022

The “Pharmaceutical Manufacturing Market Research Report by Drug Development Type, Formulation, Therapy Area, Route of Administration Outlook, Prescription, Age Group, Distribution Channels, Region – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering.

The Global Pharmaceutical Manufacturing Market size was estimated at USD 454.02 billion in 2021, USD 509.45 billion in 2022, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 12.38% to reach USD 914.90 billion by 2027.

Market Statistics:

The report provides market sizing and forecast across five major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Pharmaceutical Manufacturing to forecast the revenues and analyze the trends in each of the following sub-markets:

  • Based on Drug Development Type, the market was studied In-house and Outsourced.
  • Based on Formulation, the market was studied across Capsules, Injectable, Powders, Sprays, Suspensions, and Tablets.
  • Based on Therapy Area, the market was studied across Cancer, Cardiovascular Diseases, Diabetes, Pain, and Respiratory Diseases.
  • Based on Route of Administration Outlook, the market was studied across Inhalations, Oral, Parenteral, and Topical.
  • Based on Prescription, the market was studied across Over-the-counter (OTC) Medicines and Prescription Medicines.
  • Based on Age Group, the market was studied across Adults, Children & Adolescents, and Geriatric.
  • Based on Distribution Channels, the market was studied across Non-retail and Retail.
  • Based on Region, the market was studied across the Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. Europe, the Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and the United Kingdom.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Read more here

Source: Businesswire

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Thermo Fisher Scientific Completes Acquisition of PeproTech, a Leader in Recombinant ProteinsThermo Fisher Scientific Completes Acquisition of PeproTech, a Leader in Recombinant Proteins
  • Colorcon, Inc. Completes Acquisition of Controlled Atmosphere Packaging Specialist Airnov Healthcare PackaginColorcon, Inc. Completes Acquisition of Controlled Atmosphere Packaging Specialist Airnov Healthcare Packagin
  • Teladoc Builds Out Mental Healthcare Services with MyStrength CompleteTeladoc Builds Out Mental Healthcare Services with MyStrength Complete
  • Medical device security software startup MedCrypt pulls in $1.9MMedical device security software startup MedCrypt pulls in $1.9M
  • Global Tyrosine Kinase Inhibitors Market Insights, Trends and Technology Growth 2026Global Tyrosine Kinase Inhibitors Market Insights, Trends and Technology Growth 2026
  • Resonetics Announces Acquisition Of STI Laser IndustriesResonetics Announces Acquisition Of STI Laser Industries
  • 11 Best Practices of a Successful Care Model Transformation Plan11 Best Practices of a Successful Care Model Transformation Plan
  • IQHQ Broadens Massachusetts Life Science Portfolio With Acquisition of Innovation Park in AndoverIQHQ Broadens Massachusetts Life Science Portfolio With Acquisition of Innovation Park in Andover

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications